Ligand Pharmaceuticals (LGND) Proxy filing summary

Voting matters and shareholder proposals

• Election of eight directors, with all nominees recommended by the board for approval.

• Ratification of Ernst & Young LLP as the independent registered accounting firm for the next fiscal year.

• Advisory approval of executive compensation for named executive officers.

• Approval of an amendment and restatement of the 2002 Stock Incentive Plan.

Board of directors and corporate governance

• Board recommends voting for all eight director nominees, including individuals with diverse backgrounds in science, business, and medicine.

Executive compensation and say-on-pay

• Advisory vote on executive compensation is included as a key agenda item, reflecting ongoing shareholder engagement on pay practices.

• Proposed amendment and restatement of the 2002 Stock Incentive Plan to update equity compensation arrangements.